Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 24693444)

1.
3.

Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.

Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin-Hirsch PP, Prendiville WJ.

Cochrane Database Syst Rev. 2013 Mar 28;3:CD008054. doi: 10.1002/14651858.CD008054.pub2. Review.

PMID:
23543559
4.

[Triage value of high risk human papilloma virus detection in women with abnormal cervical cytology].

Jin Y, Pan LY, Wang YF, Cheng XM, Lang JH.

Zhonghua Yi Xue Za Zhi. 2008 Apr 29;88(17):1173-6. Chinese.

PMID:
18844110
5.

Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.

Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.

Coll Antropol. 2010 Mar;34(1):19-24.

PMID:
20432728
6.
7.

Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.

Ibáñez R, Moreno-Crespi J, Sardà M, Autonell J, Fibla M, Gutiérrez C, Lloveras B, Alejo M, Català I, Alameda F, Casas M, Bosch FX, de Sanjosé S.

BMC Infect Dis. 2012 Jan 26;12:25. doi: 10.1186/1471-2334-12-25.

8.

Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.

Arbyn M, Benoy I, Simoens C, Bogers J, Beutels P, Depuydt C.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):321-30. doi: 10.1158/1055-9965.EPI-08-0510.

11.

Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.

Gustinucci D, Passamonti B, Cesarini E, Butera D, Palmieri EA, Bulletti S, Carlani A, Staiano M, D'Amico MR, D'Angelo V, Di Dato E, Martinelli N, Malaspina M, Spita N, Tintori B, Fulciniti F.

Acta Cytol. 2012;56(5):506-14. doi: 10.1159/000338979. Epub 2012 Sep 27.

PMID:
23075891
12.

Prevalence and viral load of 51 genital human papillomavirus types and three subtypes.

Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M; VALGENT Study Group.

Int J Cancer. 2013 May 15;132(10):2395-403. doi: 10.1002/ijc.27891. Epub 2012 Oct 25.

PMID:
23034864
13.

[Application of high-risk human papillomavirus testing in women with abnormal cytology].

Ou H, Bian ML, Zhang XY, Chen QY, Li M, Chen Y, Liu J.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Oct;29(5):608-11. Chinese.

14.

Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.

Simonella LM, Lewis H, Smith M, Neal H, Bromhead C, Canfell K.

BMC Infect Dis. 2013 Mar 3;13:114. doi: 10.1186/1471-2334-13-114.

15.
16.

Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types.

Verdoodt F, Szarewski A, Halfon P, Cuschieri K, Arbyn M.

Cancer Cytopathol. 2013 Dec;121(12):675-87. doi: 10.1002/cncy.21325. Epub 2013 Jul 23. Review.

PMID:
23881840
17.

[Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].

Guo YL, You K, Geng L, Zhang XW, Shen XY, Yao YJ, Fan XH.

Beijing Da Xue Xue Bao. 2006 Oct 18;38(5):480-2. Chinese.

18.

Should LSIL-H be a distinct cytology category?: A study on the frequency and distribution of 40 human papillomavirus genotypes in 808 women.

Zhou H, Schwartz MR, Coffey D, Smith D, Mody DR, Ge Y.

Cancer Cytopathol. 2012 Dec 25;120(6):373-9. doi: 10.1002/cncy.21210. Epub 2012 May 30.

PMID:
22648956
19.
20.

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J.

Vaccine. 2012 Nov 20;30 Suppl 5:F88-99. doi: 10.1016/j.vaccine.2012.06.095. Review. Erratum in: Vaccine. 2013 Dec 16;31(52):6266.

PMID:
23199969
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk